MarkWide Research

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 373 8777

24/7 Customer Support

Smart healthcare monitoring devices market to touch US$ 8.2 Bn by 2025

The growing telecardiology usage and the ongoing development of smart monitors for healthcare applications are significant factors leading to global market growth for arrhythmia monitoring devices. Besides, arrhythmia monitoring devices’ portability is foreseen to increase its demand that can augment the market size. Following these promising developments, the Global Ambulatory Arrhythmia Monitoring Devices Market is estimated to see healthy growth, pegged at a CAGR of around 6.5% throughout the forecast period 2020-2025.

The COVID-19 has adversely impacted the arrhythmia monitoring devices market owing to the supply chain disruption. Besides, the supply chain and production process have also been affected severely. The imposition of lockdown in various emerging markets, such as India, China, South Korea, and others, is expected to hinder the market momentum in the coming years.

Trends and Opportunities: Global Arrhythmia Monitoring Devices Market

Various factors are propelling the global arrhythmia monitoring devices market development, which further comprises supportive reimbursements for disorder treatment, technological arrhythmia monitoring devices development, growing cardiovascular diseases cases, increased focus on the affordability of healthcare costs, rise in low-cost ECG facilities adoption rate for emerging markets, and favorable government regulation.

The reliance on signal quality and amplitude controlled by the devices, alongside the low popularity of telemetry innovation in developing markets and the high cost of remote cardiac arrhythmia monitoring, are blocking the market’s development. The absence of affordable cardiac arrhythmia monitoring devices is giving an immense scope in this market, while the broad infrastructural necessities keeping the penetration of small firms from expansion are at present the major hindrance witnessed by this market.

Product Innovation to Grow the Adoption of Device among Professionals

The ongoing technical development allowing remote monitoring of cardiac rhythm in patients is expected to be one of the most salient factors that can augment the market in the coming period. The high accuracy and efficiency of arrhythmia detection are expected to surge its demand, thereby raising the market. Furthermore, the growing requirement for continuous cardiac rhythm monitoring in the emergency department is expected to augment the ambulatory arrhythmia monitoring devices’ market size in the assessment period.

Growing CVDs Incidence to Offer Market Expansion Opportunities

Adopting an unhealthy diet such as consuming a sugar-rich diet, smoking, alcoholism, and higher adoption of a sedentary lifestyle are crucial factors that can offer various expansion opportunities to the ambulatory arrhythmia monitoring devices market industry.

Segmentation Overview of the Global Ambulatory Arrhythmia Monitoring Devices Market

The ambulatory arrhythmia monitoring devices market is segmented based on Device Type, Application, and End-User. These major market segments are further categorized into various sub-segments to study the market in detail.

By Device Type Outlook (Resting ECG, Event Monitor, Implantable Cardiac Monitor, Holter Monitor, Mobile Cardiac Telemetry Devices, Others)

By Application Outlook (Tachycardia, Bradycardia, Atrial Fibrillation, Ventricular Fibrillation, Conduction Disorders, Others)

By End-User Outlook (Hospitals Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Homecare Settings, Others)

Key Players Insights

Abbott Laboratories, Fukuda Denshi Co. Ltd, BioTelemetry Inc., Applied Cardiac Systems Inc., Medtronic plc, Nihon Kohden Corporation, Biotronik, Alive Cor Inc., Spacelabs Healthcare, and GE Healthcare, among others, are the prominent ambulatory arrhythmia monitoring devices companies included during the research study.

Leave a Comment